ACCESS TO PEPTIDE REGIONS OF A SURFACE MUCIN (MUC1) IS REDUCED BY SIALIC ACIDS

被引:38
|
作者
HO, JJL [1 ]
CHENG, S [1 ]
KIM, YS [1 ]
机构
[1] UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA
关键词
D O I
10.1006/bbrc.1995.1738
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mucinous glycoproteins are present on the surfaces of tumor cells. Knowledge of which parts of the mucin molecule are accessible targets for cells of the immune system is important in the development of successful therapeutic approaches. One breast (ZR-75-1), two colon (Colo 205 and SW1116), and three pancreas (Capan-2, HPAF and SW1990) cancer cell lines were examined. The reactivities of antibodies HMFG-2, specific for the tripeptide (DTR) in the 20 amino acid tandem repeat of MUC1, and SM-3 (PDTRP) were greatly enhanced by pre-treating cells with an inhibitor of O-glycosylation, benzyl-alpha-N-acetylgalactosamide. However, desialylation of cell surfaces with neuraminidase or pre-treatment with an inhibitor of carbohydrate processing, monensin, also greatly enhanced the reactivities of HMFG-2, SM-3 and HMFG-1 (PDTR). Thus, sialic acids on termini of neighboring oligosaccharides significantly limit access to the peptide region recognized by antibodies HMFG-1/2 and SM-3. (C) Academic Press, Inc.
引用
收藏
页码:866 / 873
页数:8
相关论文
共 50 条
  • [41] Abnormal expression of MUC1 apomucin and mature MUC1 mucin in biliary epithelial cells in various cystic liver diseases
    Sasaki, M
    Nakanuma, Y
    HEPATOLOGY, 1996, 24 (03) : 539 - 543
  • [42] Mucin-1 (MUC1) as a promising molecular target in anticancer therapy
    Gornowicz, Agnieszka
    Bielawska, Anna
    Poplawska, Bozena
    Bielawski, Krzysztof
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2019, 73 : 53 - 64
  • [43] DETECTION OF A CIRCULATING ANTIBODY AGAINST A PEPTIDE EPITOPE ON A MUCIN CORE PROTEIN, MUC1, IN ULCERATIVE-COLITIS
    HINODA, Y
    NAKAGAWA, N
    NAKAMURA, H
    MAKIGUCHI, Y
    ITOH, F
    ADACHI, M
    YABANA, T
    IMAI, K
    YACHI, A
    IMMUNOLOGY LETTERS, 1993, 35 (02) : 163 - 168
  • [44] The Roles of the Juxtamembrane Cysteine and Glutamine Residues in Mucin 1 (MUC1) Dimerization
    Li, Edwin
    Herrera, Roberto
    Cani, Ksandros
    Freeman, Christina
    FASEB JOURNAL, 2018, 32 (01):
  • [45] Role of endocytosis in the maturation of the membrane-associated mucin MUC1
    Altschuler, Y
    Poland, PA
    Kinlough, CL
    Hughey, RP
    MOLECULAR BIOLOGY OF THE CELL, 1997, 8 : 1745 - 1745
  • [46] Tissue and serum MUC1 mucin detection in breast cancer patients
    Croce, MV
    Isla-Larrain, MT
    Demichelis, SO
    Gori, JR
    Price, MR
    Segal-Eiras, A
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 81 (03) : 195 - 207
  • [47] Dendritic cell vaccine immunotherapy of cancer targeting MUC1 mucin
    Kontani, K
    Taguchi, O
    Ozaki, Y
    Hanaoka, J
    Sawai, S
    Inoue, S
    Abe, H
    Hanasawa, K
    Fujino, S
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2003, 12 (04) : 493 - 502
  • [48] MHC-restricted presentation of a single repeat of MUC1 mucin
    Orr, Melody K.
    Burnside, Janet S.
    Phillips, Catherine A.
    Philip, Ramila
    Dombrowski, Kenneth E.
    Wright, Stephen E.
    IMMUNOLOGICAL INVESTIGATIONS, 2007, 36 (03) : 271 - 283
  • [49] Expression of mucin 1 (MUC1) in benign, premalignant and malignant vulvar tumors
    Wu, X
    Yao, JF
    Xin, Y
    Tsuyama, S
    Yonezawa, S
    Murata, F
    ACTA HISTOCHEMICA ET CYTOCHEMICA, 2000, 33 (04) : 267 - 273
  • [50] Aberrant Expression of MUC1 Mucin in Pediatric Inflammatory Bowel Disease
    Furr, Anna E.
    Ranganathan, Sarangarajan
    Finn, Olivera J.
    PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 2010, 13 (01) : 24 - 31